Lawrence J Knopf Receives Stock Award at SQZ Biotechnologies Co (SQZ) — SEC Form 4, Jan 04, 2022
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Equity Position
454 sh
0 → 454
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Lawrence J Knopf CIK 0001517214 |
GC
|
Lawrence J Knopf at SQZ Biotechnologies Co
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at SQZ Biotechnologies Co
| 2023-01-26 | Award | — | View |
| 2022-07-05 | Award | — | View |
| 2022-02-15 | Award | — | View |
| 2021-02-25 | Award | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2021-12-31 | A - Award/Grant | 454 A | $7.59 | +$3,446 | 454 | Direct |
Footnotes (1)
- F1
- The reporting person is voluntarily reporting the acquisition on December 31, 2021 of 454 shares of the issuer's common stock pursuant to the issuer's employee stock purchase plan. Show more
Related filings at SQZ Biotechnologies Co
Other insiders at SQZ Biotechnologies Co
GET /v1/forms/4/0001209191-22-000982
API docs
View Original SEC Filing